Bain Capital Life Sciences Investors, LLC X4 Pharmaceuticals, Inc Transaction History
Bain Capital Life Sciences Investors, LLC
- $489 Million
- Q2 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 16,915,784 shares of XFOR stock, worth $11.2 Million. This represents 2.01% of its overall portfolio holdings.
Number of Shares
16,915,784
Previous 16,915,784
-0.0%
Holding current value
$11.2 Million
Previous $23.5 Million
58.27%
% of portfolio
2.01%
Previous 3.55%
Shares
8 transactions
Others Institutions Holding XFOR
# of Institutions
107Shares Held
101MCall Options Held
418KPut Options Held
71.7K-
Nea Management Company, LLC Timonium, MD15MShares$9.89 Million0.82% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$7.05 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.29MShares$5.47 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.13MShares$4.71 Million0.1% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY4.62MShares$3.05 Million0.31% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $45.3M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...